Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Targovax and Papyrus Therapeutics enter research collaboration to develop novel ONCOS viruses with receptor tyrosine kinase (RTK) inhibitor functionality

· The parties will explore the feasibility and effect of combining their respective oncolytic virus and receptor tyrosine kinase (RTK) inhibitor technologies · Targovax retains the right to develop and commercialize novel drug candidates emerging from the pre-clinical collaboration Oslo, Norway 10 February 2021 – Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces that it has entered into a research collaboration agreement with Papyrus Therapeutics to assess the potential of combining

STOREBRAND ASA: Results for the 4th Quarter 2020

Leading the Way in Sustainable Value Creation – Strongest Quarter on Record· Group profit[1] of NOK 1,225m in the 4th quarter, strongest on record · Solvency II ratio 178% · Proposed dividend of NOK 3.25 per share · Total Assets under Management (AuM): NOK 962bn, 16% growth y/y – The Storebrand Group delivers its strongest quarter on record, driven by continued growth in assets under management and insurance premiums. The Group's profit grew by 19 per cent to NOK 1,225 million in the fourth quarter, compared to last year. Underlying growth within the core business Savings and

ICA Gruppen Year-end report 2020

Strong close to the year with continued pandemic impactsFourth quarter 2020 · Consolidated net sales increased by 5.6% to SEK 32,593 million (30,850) · Operating profit excluding items affecting comparability increased to SEK 1,371 million (1,267). Overall, non-recurring items in operating profit are considered to be insignificant. In operating profit for 2019, these were calculated at SEK -50 million net. · Consolidated sales and operating profit were affected by the continuing Covid-19 pandemic, where ICA Sweden and ICA Real Estate benefited, while other segments were

BERGENBIO ASA: RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2020

Bergen, Norway, 10 February 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, announces its results for the fourth quarter and full year 2020. A presentation and live webcast by BerGenBio’s senior management will take place at 10.00 am CET today, please see below for details. Operational Highlights – fourth quarter (including post-period end)  · First patient enrolled in South Africa and India as part of Company sponsored randomised Phase II trial assessing bemcentinib as a

Panoro Energy – US$ 70 Million Oversubscribed Private Placement Successfully Completed – Mandatory notification of trades

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 10 February 2021 Reference is made to the stock exchange release by Panoro Energy ASA (the “Company” or “Panoro”, with OSE Ticker: “PEN”) on 9 February 2021 regarding a contemplated private placement (the “Private Placement”) of new shares in the Company with

Kristofer Liljeberg appointed new Head of Research at Carnegie

Kristofer Liljeberg, one of the most experienced and highly regarded equity analysts in Sweden, is the new Head of Swedish Research at Carnegie. Mr Liljeberg has been with Carnegie for 25 years, where his principal focus has been healthcare sector research.“Research is a cornerstone of all Carnegie advisory. Our ambition is to maintain the broadest research coverage of Nordic companies with no ‘sponsored research’. In line with our plans to further expand the number of companies we cover, we have recently carried out several recruitments across a range of sectors,” says Liljeberg.

Deep seabed mining is an avoidable environmental disaster

New report, “In Too Deep: What We Know, And Don’t Know, About Deep Seabed Mining,” outlines likely impacts of deep seabed mining on ecosystems and biodiversity, and risks of allowing industry to proceed.Lisbon, 10 February 2021 – The investigation “In Too Deep: What We Know, And Don’t Know, About Deep Seabed Mining”, released today by WWF, argues that there are many unknowns and much to do in ocean science, policy and industry innovations before any deep seabed mining activities should be allowed to take place.WWF says industry plans to mine the deep seabed for metals and minerals such as

Notice of extraordinary general meeting of Vicore Pharma Holding AB (publ)

The shareholders of Vicore Pharma Holding AB (publ), Reg. No. 556680-3804, with registered office in Gothenburg, are summoned to the extraordinary general meeting Friday 5 March 2021.The continued spread of COVID-19 remains difficult to assess with any certainty. Due to the prevailing extraordinary situation, Vicore Pharma’ s extraordinary general meeting will be held in a different way than usually. Vicore Pharma is mindful of the health of the shareholders as well as the work to limit the spread of the virus. Thus, in order to reduce the risk of spreading the virus and having regard to

Vicore Pharma has completed a directed share issue of SEK 336 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURESGothenburg, February 10, 2021 – Vicore Pharma Holding AB (publ) (“Vicore Pharma” or the “Company”), announces, as indicated in the Company’s press release earlier today, that the Company has successfully completed a

Lucara 2020 Year End Results to be Released Monday, February 22, 2021

February 9, 2021 Vancouver, British Columbia /CNW/ (LUC – TSX, LUC – BSE, LUC – Nasdaq Stockholm) Lucara Diamond Corp. (“Lucara” or the “Company”) announces that it will be publishing its 2020 Year End Results on Monday, February 22, 2021 after market close in North America.   The Company will host a conference call and webcast to discuss the results on Tuesday, February 23, 2021 at 7:00 a.m. Pacific, 10:00 a.m. Eastern, 3:00 p.m. UK, 4:00 p.m. CET. CONFERENCE CALL:Please call in 10 minutes before the conference call starts and stay on the line (an operator will be available to

Asetek A/S Announces Transactions Carried Out Under the Current Share Buyback Programme in Accordance With the "Safe Harbour Method"

February 9, 2021 - On October 23, 2020, Asetek A/S launched a share buyback programme, as described in company announcement of October 23, 2020. According to the programme, Asetek A/S will in the period until March 5, 2021 buy back own shares up to a maximum value of USD 4 million and with a maximum of 381,000 shares. The share buyback programme will be implemented in accordance with Regulation (EU) no. 596/2014 of 16th April 2014 of the European Parliament and Council and Commission Delegated Regulation (EU) no. 2016/1052, also referred to as the Safe Harbour rules. Trading day

Notification of the holdings by Sand Grove Capital Management

Tikkurila OyjMajor Shareholders Announcement9 February 2021 at 9.30 p.m. (EET) Tikkurila Oyj (business ID 0197067-4) has on 9 February 2021, received a notification pursuant to the Finnish Securities Markets Act, Chapter 9, Section 10, from Sand Grove Capital Management LLP. According to the notification, the holding of the funds and accounts managed by Sand Grove Capital Management in the shares of Tikkurila Oyj has decreased to 0 percent, due to the trades executed on February 8, 2021. The position of previous holding by Sand Grove Capital Management, announced on 19 January

Bemobi IPO successfully completed

Otello ASA (Oslo) announces that Bemobi Mobile Tech S.A.  ("Bemobi Brasil"), the parent company of Otello's activities in Brazil and internationally, has set a price of R$22.00 per common share for its Initial Public Offering (IPO), determined after completion of the bookbuilding process. Based on this price, the gross proceeds of the primary component of the IPO, will reach R$ 1,094,117,684 ($203,943,536), resulting in an equity value, post-money, of Bemobi Brasil at IPO of R$2,000,000,024 ($372.800.004). The Brazilian Final Prospectus related to the IPO will be filed today with the

DNB Markets - IAR Systems: "Next year is IAR Systems' year"...

… is something we have been saying since 2019 and, while the burden of proof is heavy, we remain confident that the investment community should see early signs of 64-bit, RISC-V, and security traction in 2021e. This could spark a shift in perception given the vast market opportunity to reignite a ~15% organic sales CAGR and revisit 30%+ EBIT margins. Our SEK180–250 fair value corresponds to a 2022e P/E of 27x.Q4 takeaways. An organic sales decline of 11% YOY (our estimate: -8%) as, while existing clients continue to buy support and maintenance licences, new business wins are weak as

Q-Free: Acceptances received under mandatory offer to acquire all shares in Q-Free ASA

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the Offer, the distribution of this stock exchange announcement or the acceptance of any tender of shares would contravene applicable laws or regulations. (Oslo, 9 February 2021): Reference is made to the mandatory offer (the “Offer”) from Rieber & Søn AS (the “Offeror”) to acquire all shares in Q-Free ASA (“Q-Free” or the “Company”) pursuant to an offer document

Akelius issues EUR bond

Akelius Residential Property Financing B.V. has issued aEUR 600 million senior unsecured bond. The bond matures 2030-02-22.The annual coupon is 0.75 percent. The bond will be listed on Euronext Dublin and has identification number XS2301127119. Standard and Poor’s has confirmed the rating of BBB on the bond. Akelius Residential Property AB (publ) guarantees the bond. BNP Paribas, Danske Bank, and Swedbank were the arrangers.   Stockholm, 2021-02-09 Leiv SynnesCFO, Vice President+46 70 558 55 23leiv.synnes@akelius.se   Akelius Residential Property AB’s

Notice of Extra General Meeting in Embracer Group AB

The shareholders of Embracer Group AB, reg. no. 556582-6558, (the "Company") are hereby invited to the extra general meeting on Friday 26 February 2021 at 10.00 CET at Baker McKenzie's premises at Vasagatan 7 in Stockholm.Information with respect to the coronavirus Due to the development of the coronavirus the goal is that the extra general meeting shall be swift and effective to minimize spread of disease. Shareholders should carefully consider the possibility to vote in advance, please see below, as well as the possibility of participating by way of proxy or video conference.

Vicore Pharma intends to carry out a directed share issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURESGothenburg, February 9, 2021 – Vicore Pharma Holding AB (publ) (“Vicore Pharma” or the “Company”) today announces its intention to carry out a directed share issue corresponding to approximately SEK 300 million to

IVC Evidensia expands partnership to drive next phase of accelerating growth

· Europe’s largest veterinary care provider welcomes additional investment and renewed long-term commitment from largest shareholder EQT Private Equity · New minority investment from technology leader Silver Lake validates success to date and compelling opportunities ahead  · The expanded partnership is expected to accelerate continued growth and further broaden IVC’s digitalization and innovation capabilities IVC Evidensia (“IVC” or “the Company”), Europe’s largest veterinary care provider, announces an expanded partnership among its shareholders to support IVC in driving its

Fazer Bakery in Sweden lays the foundation for the future – implements a new reseller model with Polfärskt and closes the bakery in Lund

· In order to improve the service level of Fazer Bakery Sweden towards its customers, Fazer has entered a reseller agreement with the bakery sales company Polfärskt. The agreement will come into effect from the beginning of the summer 2021. As a result, Fazer Bakery’s organisation for field sales and distribution in Sweden will be discontinued. · The reseller agreement only covers sales and distribution to retail. Fazer Bakery Sweden will continue to have its own sales organisation managing central customer relations and campaigns with Swedish retail as well as sales to restaurants, food

Focus Your Power in New Europa Universalis IV Expansion

“Leviathan” Gives Players More Development OptionsSTOCKHOLM - February 9, 2021 - Picture a capital city that shines like a gemstone, improved by the wealth drawn from the hinterland - decorated by riches demanded from vassals. A capital not of a mighty territorial empire, but of a compact and concentrated state that can still use gold and favors to influence neighbors and rivals. Picture it and then make it so in Europa Universalis IV: Leviathan. Leviathan is the newest expansion to Paradox’s flagship grand strategy game about the early modern world. Leviathan offers new tools that allow

Panoro Energy Announces Transformational Acquisition of Producing Assets in West Africa and Contemplated Equity Private Placement of US$ 70 million

Oslo, 9 February 2021 - Panoro Energy ASA (the “Company” or “Panoro”) is pleased to announce that it has entered into agreements with Tullow Oil plc and its subsidiaries (“Tullow”) to acquire high-quality oil producing assets offshore Equatorial Guinea and Gabon for an initial aggregate cash consideration of up to US$ 140 million and aggregate contingent consideration of up to US$ 40 million, based on an effective date of 1 July 2020 (collectively the “Acquisitions”). Highlights · Acquisitions of 14.25% working interest (“WI”) in Block G, offshore Equatorial Guinea, and an

Panoro Energy ASA - Contemplated Private Placement to Finance Transformational Acquisitions in West Africa

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO BUY OR SUBSCRIBE OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 9 February 2021 Panoro Energy ASA (the "Company" or "Panoro" with OSE ticker: "PEN") announces, in conjunction with the acquisitions of producing assets in West Africa from subsidiaries of Tullow Oil plc (the “Acquisitions”), a

Change in the holding of Kesko Corporation’s treasury shares

A total of 6,272 B shares (KESKOB) have been returned to Kesko Corporation without consideration in accordance with the terms and conditions of Kesko's Performance Share Plan PSP 2017-2020, Bridge Plan 2017-2020, and PSP 2018-2021. The shares had initially been granted to a person included in the target groups of the 2017, 2018 and 2019 performance periods of the plans. Following the return of the shares, Kesko holds 3,346,134  of its own B shares as treasury shares. Further information is available from Matti Mettälä, Executive Vice President, tel. +358 105 322 200.  Kesko

There are no items matching the current filter
There are no more items matching the current filter
Back to top